An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

Conditions

• Various Advanced Cancer

Interventions

• BIOLOGICAL: Nivolumab
• OTHER: Placebo

Sponsor

Bristol-Myers Squibb

Collaborators

• [object Object]